CNK
Cinemark Holdings, Inc.
CNK's outlook is improving, though it still trails on the overall score.
META
Meta Platforms, Inc.
META has the edge over CNK overall, supported by lower modeled downside and stronger valuation.
CNK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Weak |
CNK's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is weak.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CNK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $34.01 | -18% |
| Forward | 16x | $41.46 | — |
| Current | 17x | $41.46 | — |
| Fair | 20x | $49.22 | +19% |
| Expensive | 23x | $58.34 | +41% |
Historical ranges are pointers, not guarantees.
CNK's PE is in its fair range at 17x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over CNK in the historical PE scenario, which offers more potential upside but is not a forecast.
CNK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CNK, with profitability improving. However, they disagree widely on these estimates.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
CNK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.62 | +4.9% |
| Q3 2026 | $2.50 | +134% |
| Q2 2026 | $1.86 | 0% |
| Q1 2026 | $1.30 | -16% |
| Q4 2025 | $1.04 | -50% |
| Q1 2023 | -$1.67 | +$0.75 |
| Q4 2022 | -$2.26 | +$1.29 |
| Q3 2022 | -$1.39 | +$4.23 |
| Q2 2022 | -$1.84 | +$4.38 |
CNK earned $2.50 per share over the past year, up 134% from the year before.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over CNK on earnings, with more consistent year-over-year improvement.
CNK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +24% |
| Q2 2026 | $1.1B | +16% |
| Q1 2026 | $643.1M | +19% |
| Q4 2025 | $776.3M | -4.7% |
| Q3 2025 | $857.5M | -7% |
| Q2 2025 | $940.5M | +28% |
| Q1 2025 | $540.7M | -6.6% |
| Q4 2024 | $814.3M | +27% |
CNK's revenue is growing: $1.1B last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -2.5% | +27 points |
| Q1 2022 | -7.2% | +141 points |
| Q4 2021 | 6.7% | +299 points |
| Q3 2021 | -9.8% | +584 points |
| Q2 2021 | -29% | +2359 points |
| Q1 2021 | -148% | -140 points |
| Q4 2020 | -292% | -301 points |
| Q3 2020 | -594% | N/A |
CNK's operating margin was −2.5% last quarter, up 27 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over CNK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META's operating margin was 20% last quarter, down 20 points from the same quarter a year ago, near the bottom of its range since 2019.
CNK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2022 | -$43.1M | +$2.1M |
| Q2 2022 | $143M | +63% |
| Q1 2022 | -$137.5M | +$4.3M |
| Q4 2021 | $170.1M | +$348.9M |
| Q3 2021 | -$45.2M | -$10.8M |
| Q2 2021 | $87.5M | +$238.6M |
| Q1 2021 | -$141.8M | -$92.1M |
| Q4 2020 | -$178.8M | -475% |
CNK has the stronger cash trend. Its trailing FCF is up 177% versus its history, compared with META at down 24%.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
CNK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -6% | -7.4M shares |
| 3 years | -23% | -35.6M shares |
| 5 years | -0.7% | -874K shares |
| Available history | -0.2% | -206K shares |
CNK has the edge over META on shareholder dilution, with a more favorable share count trend.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
CNK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 8.9x | High |
| Q1 2022 | 13.6x | High |
| Q4 2021 | 139.1x | High |
| Q2 2020 | 12.1x | High |
| Q1 2020 | 2.8x | Moderate |
| Q4 2019 | 2.2x | Moderate |
CNK's net debt is about 8.9 years of its operating earnings (EBITDA), up from 2.8 years a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
CNK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.5 | Neutral |
| Stochastic | 82.2 | Overbought |
CNK's weekly RSI is 69 (neutral) and its Stochastic is 82 (overbought).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
CNK PE vs Communication Services Sector
| Metric | CNK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 16x | 0.5% above |
| PE % | 36 | 26 | 10 pts above |
CNK has the edge over META on valuation relative to its sector.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
CNK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 7.7% above |
| 20 week MA | $36.0 | 15% above |
| 50 week MA | $30.6 | 36% above |
| 100 week MA | $29.6 | 40% above |
| 200 week MA | $24.3 | 71% above |
CNK has the edge over META on trend strength, trading above more of its moving averages.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
CNK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.0 | $16.5 | -51% |
| 2021 | $16.5 | $17.4 | +5.6% |
| 2022 | $17.4 | $8.64 | -50% |
| 2023 | $8.64 | $14.1 | +63% |
| 2024 | $14.1 | $31.0 | +120% |
| 2025 | $31.0 | $22.9 | -26% |
| 2026 YTD | $22.9 | $41.5 | +81% |
CNK has the edge over META on returns for 2026, with the stronger performance.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.